No Data
No Data
No Data
Merck (NYSE:MRK) Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion
Zacks Investment Ideas Feature Highlights: Molson Coors, Merck & Co. and Deutsche Telekom
Express News | Merck & Co- Expect to Invest Another $8 Bln of U.S. Capital by 2028
Express News | Merck & Co Inc - Opens $1 Billion Vaccine Manufacturing Facility in Durham
Express News | Merck Unveils New Facility to Increase Vaccine Production Capacity
Merck & Co. (MRK): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now